Atopic dermatitis is one of the most common chronic diseases of childhood and closely related to other clinical manifestations of allergy.
过敏性皮炎是儿童最常见的慢性疾病之一，它和其它临床过敏表现极度相关。
The suggested formulation is also effective in treatment of other inflammatory skin diseases such as psoriasis, atopic dermatitis and common acne.
本发明所公开的配制品同样在其他炎症性皮肤疾病 （例如牛皮癣、特应性皮炎和寻常痤疮）的治疗中同样有效。
If no improvement occurs after 6 weeks of treatment, or exacerbation of atopic dermatitis is observed, treatment should be stopped and other therapeutic options considered.
如果在治疗后6个星期治疗没有改善发生，或观察到出现遗传性过敏皮炎恶化，治疗应该停止并考虑选择其他治疗。
If no improvement occurs after 6 weeks of treatment, or exacerbation of atopic dermatitis is observed, treatment should be stopped and other therapeutic options considered.
如果在治疗后6个星期治疗没有改善发生，或观察到出现遗传性过敏皮炎恶化，治疗应该停止并考虑选择其他治疗。
应用推荐